首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2018年 8期 自身免疫性胰腺炎 => 专家论坛 =>IgG4相关性自身免..
IgG4相关性自身免疫性胰腺炎治疗中免疫抑制剂的应用
Application of immunosuppressant in IgG4-related autoimmune pancreatitis
文章发布日期:2018年07月06日  来源:  作者:张盼盼,张文  点击次数:519次  下载次数:93次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:1型自身免疫性胰腺炎即IgG4相关性自身免疫性胰腺炎目前治疗的首选药物是糖皮质激素。免疫抑制剂与糖皮质激素联合治疗有助于激素减量,并维持疾病的长期缓解。目前对于IgG4相关性疾病的免疫抑制剂治疗,缺乏循证级别较高的前瞻性研究,国际和国内尚无统一规范,主要借鉴其他自身免疫病的经验。介绍了传统药物包括硫唑嘌呤、吗替麦考酚、环磷酰胺、甲氨蝶呤、来氟米特、环孢霉素等,以及生物治疗如靶向B淋巴细胞的利妥昔单抗在该病治疗中的应用情况。
【Abstract】:At present, glucocorticoids are the first-line drugs for the treatment of type 1 autoimmune pancreatitis, which is also known as IgG4-related autoimmune pancreatitis. Combined treatment with immunosuppressant and glucocorticoids helps to reduce the dose of glucocorticoids and maintain long-term remission. There are no high-quality evidence-based prospective studies of immunosuppressant in the treatment of IgG4-related disease. No uniform standards have been developed in China and the rest of the world, and the treatment of this disease mainly draws experience from other autoimmune diseases. This article introduces the application of conventional drugs (including azathioprine, mycophenolate mofetil, cyclophosphamide, methotrexate, leflunomide, and cyclosporine) and biological therapy (for example, rituximab targeting B lymphocytes) in the treatment of autoimmune pancreatitis.
【关键字】:胰腺炎; 自身免疫疾病; 免疫球蛋白G; 免疫抑制剂
【Key words】:pancreatitis; autoimmune diseases; immunoglobulin G; immunosuppressive agents
【引证本文】:ZHANG PP, ZHANG W. Application of immunosuppressant in IgG4-related autoimmune pancreatitis[J]. J Clin Hepatol, 2018, 34(8): 1614-1618. (in Chinese)
张盼盼, 张文. IgG4相关性自身免疫性胰腺炎治疗中免疫抑制剂的应用[J]. 临床肝胆病杂志, 2018, 34(8): 1614-1618.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号